Styran Global Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 1077.07%
(FY 2022)
- Profit -24.70%
(FY 2022)
- Ebitda -27.92%
(FY 2022)
- Net Worth -95.98%
(FY 2022)
- Total Assets 142.09%
(FY 2022)
About Styran Global Lifesciences
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Krishna Devi and Krishna Bhattacharjee serve as directors at the Company.
- CIN/LLPIN
U52510DL2020PTC368578
- Company No.
368578
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Styran Global Lifesciences Private Limited offer?
Styran Global Lifesciences Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Herbal Oil.
Who are the key members and board of directors at Styran Global Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Devi  | Director | 24-Aug-2020 | Current |
| Krishna Bhattacharjee | Director | 24-Aug-2020 | Current |
Financial Performance of Styran Global Lifesciences.
Styran Global Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1077.07% increase. The company also saw a substantial fall in profitability, with a 24.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 95.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Styran Global Lifesciences?
Unlock access to Styran Global Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Styran Global Lifesciences?
Styran Global Lifesciences has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Styran Global Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Styran Global Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
